{
    "ticker": "TPTA",
    "name": "Titan Pharmaceuticals, Inc.",
    "description": "Titan Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of chronic conditions. Founded in 1992, Titan aims to improve patient outcomes by leveraging its proprietary drug delivery technologies and formulations. The company is primarily known for its work with the ProNeura\u2122 implantable drug delivery system, which allows for continuous release of therapeutics over extended periods, thereby enhancing patient compliance and providing more effective treatment options. Titan's lead product candidate, Probuphine, is designed for the treatment of opioid dependence and has received FDA approval. The company is also exploring other potential applications of its technology, including treatments for various neurological and psychiatric disorders. With a commitment to research and development, Titan Pharmaceuticals strives to address unmet medical needs and improve the quality of life for patients.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "1992",
    "website": "http://www.titanpharm.com",
    "ceo": "Chad A. McClain",
    "social_media": {
        "twitter": "https://twitter.com/TitanPharma",
        "linkedin": "https://www.linkedin.com/company/titan-pharmaceuticals/"
    },
    "investor_relations": "http://www.titanpharm.com/investor-relations",
    "key_executives": [
        {
            "name": "Chad A. McClain",
            "position": "CEO"
        },
        {
            "name": "Dr. David A. Gibbons",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Drug Delivery Systems",
            "products": [
                "Probuphine"
            ]
        }
    ],
    "seo": {
        "meta_title": "Titan Pharmaceuticals, Inc. | Innovative Drug Delivery Solutions",
        "meta_description": "Explore Titan Pharmaceuticals, Inc., a leader in drug delivery systems for chronic conditions. Learn about our innovative therapies and commitment to patient care.",
        "keywords": [
            "Titan Pharmaceuticals",
            "Drug Delivery",
            "Biotechnology",
            "Probuphine",
            "Opioid Dependence"
        ]
    },
    "faq": [
        {
            "question": "What is Titan Pharmaceuticals known for?",
            "answer": "Titan Pharmaceuticals is known for its innovative drug delivery systems, particularly the ProNeura\u2122 system and its lead product Probuphine."
        },
        {
            "question": "Who is the CEO of Titan Pharmaceuticals?",
            "answer": "Chad A. McClain is the CEO of Titan Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Titan Pharmaceuticals headquartered?",
            "answer": "Titan Pharmaceuticals is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What are Titan's main products?",
            "answer": "Titan's main product is Probuphine, used for the treatment of opioid dependence."
        },
        {
            "question": "When was Titan Pharmaceuticals founded?",
            "answer": "Titan Pharmaceuticals was founded in 1992."
        }
    ],
    "competitors": [
        "ACAD",
        "NERV",
        "HRTX"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BIIB",
        "VRTX"
    ]
}